Daiichi Sankyo Belgium N.V.-S.A.
Daiichi Sankyo Belgium N.V.-S.A., a prominent subsidiary of the global pharmaceutical company Daiichi Sankyo, is headquartered in Belgium and operates extensively across Europe. Founded in 2005, the company has established itself in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular diseases, and vaccines.
Daiichi Sankyo is renowned for its commitment to research and development, with a portfolio that includes unique therapeutic solutions designed to address unmet medical needs. The company’s advanced drug delivery systems and targeted therapies set it apart in a competitive market. With a strong market position, Daiichi Sankyo Belgium has achieved significant milestones, contributing to the advancement of healthcare in the region and beyond.
+26 vs industry average
Daiichi Sankyo Belgium N.V.-S.A.’s score of 65 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Daiichi Sankyo Belgium N.V.-S.A.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Daiichi Sankyo Belgium N.V.-S.A. yet.
Daiichi Sankyo Belgium N.V.-S.A.'s reported carbon emissions
Daiichi Sankyo Belgium N.V.-S.A. currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific emissions figures. The company is a current subsidiary of Daiichi Sankyo Company, Limited, which may influence its climate commitments and initiatives.
As part of its corporate family, Daiichi Sankyo Belgium N.V.-S.A. adheres to the climate strategies and targets set by its parent company. These include initiatives related to the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from Daiichi Sankyo Company, Limited. However, specific reduction targets or achievements for Daiichi Sankyo Belgium N.V.-S.A. have not been disclosed.
In the absence of direct emissions data, it is important to note that the company is likely aligned with industry standards for climate action, focusing on reducing its carbon footprint and enhancing sustainability practices as part of its parent company's broader environmental commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Daiichi Sankyo Belgium N.V.-S.A.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Daiichi Sankyo Belgium N.V.-S.A. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Daiichi Sankyo Company, Limited
Carbon Disclosure Project
Inherited from Daiichi Sankyo Company, LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from Daiichi Sankyo Company, LimitedClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project